The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ventolin Nebules 5mg/2.5ml Nebuliser Solution

5 mg/2.5 millilitre(s) Nebuliser solution

GlaxoSmithKline (Ireland) LimitedPA1077/049/009

Main Information

Trade NameVentolin Nebules 5mg/2.5ml Nebuliser Solution
Active SubstancesSalbutamol
Strength5 mg/2.5 millilitre(s)
Dosage FormNebuliser solution
Licence HolderGlaxoSmithKline (Ireland) Limited
Licence NumberPA1077/049/009

Group Information

ATC CodeR03AC Selective beta-2-adrenoreceptor agonists
R03AC02 salbutamol

Status

Authorised/WithdrawnAuthorised
Licence Issued17/04/1998
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0078-139-052
Interchangeable List DocumentPDF of Interchangeable List
« Back